Cargando…
Metabolic associated fatty liver disease and COVID-19: a double whammy?
Autores principales: | Lin, Jaime Hui Xian, Aravamudan, Veeraraghavan Meyyur |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678140/ https://www.ncbi.nlm.nih.gov/pubmed/33047142 http://dx.doi.org/10.11622/smedj.2020141 |
Ejemplares similares
-
Remdesivir in Coronavirus Disease 2019 (COVID-19) treatment: a review of evidence
por: Lin, Hui Xian Jaime, et al.
Publicado: (2021) -
Commentary: Glaucoma following penetrating keratoplasty: A double whammy
por: Das, Mano Ranjan, et al.
Publicado: (2022) -
Evidence that an APOE ε4 'double whammy' increases risk for Alzheimer's disease
por: Caesar, Ina, et al.
Publicado: (2012) -
Clostridium difficile Infection in Liver Cirrhosis Carries a Higher Risk of Mortality: A Comprehensive Literature Review
por: Meyyur Aravamudan, Veeraraghavan, et al.
Publicado: (2019) -
Osteonecrosis of the Jaw and Concomitant Atypical Femoral Fractures with Bisphosphonates: A Comprehensive Literature Review
por: Meyyur Aravamudan, Veeraraghavan, et al.
Publicado: (2019)